Motl, Susannah E <br/><br/>
Delayed-onset grade 4 neutropenia associated with rituximab therapy in a patient with lymphoma: case report and literature review.  [electronic resource] 

 -  Pharmacotherapy  Aug 2005 
 - 1151-5 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Review 
<br/><br/><label>ISSN: </label>0277-0008 
<br/><br/><label>Standard No.: </label>10.1592/phco.2005.25.8.1151  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antineoplastic Agents--adverse effects<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Humans<br/>Leukocyte Count<br/>Lymphoma--complications<br/>Male<br/>Middle Aged<br/>Neutropenia--blood<br/>Prognosis<br/>Rituximab